Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760

Watchlist Manager
Shenzhen Mindray Bio-Medical Electronics Co Ltd Logo
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Watchlist
Price: 256.55 CNY 0.62% Market Closed
Market Cap: 311.1B CNY
Have any thoughts about
Shenzhen Mindray Bio-Medical Electronics Co Ltd?
Write Note
Shenzhen Mindray Bio-Medical Electronics Co Ltd
/
Balance Sheet
/
Accounts Receivables

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Accounts Receivables
¥4B
CAGR 3-Years
27%
CAGR 5-Years
17%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Accounts Receivables
¥41.4m
CAGR 3-Years
-2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Accounts Receivables
¥1.1B
CAGR 3-Years
13%
CAGR 5-Years
-6%
CAGR 10-Years
6%
J
Jafron Biomedical Co Ltd
SZSE:300529
Accounts Receivables
¥72m
CAGR 3-Years
-39%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Accounts Receivables
¥2.1B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
10%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Accounts Receivables
¥3.3B
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shenzhen Mindray Bio-Medical Electronics Co Ltd
Glance View

Market Cap
311.1B CNY
Industry
Health Care

In the bustling city of Shenzhen, China, a thriving enterprise known as Shenzhen Mindray Bio-Medical Electronics Co., Ltd, has cemented its place within the global medical devices market. Born in 1991 amid the backdrop of China’s rapid economic expansion, Mindray embarked on an ambitious journey to revolutionize healthcare technology. The company operates across three main segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. Each category is crucial to the medical infrastructure, with patient monitoring systems tracking vital statistics in real-time, in-vitro diagnostics facilitating intricate lab testing, and medical imaging enabling precise internal examinations. The synergy among these segments allows Mindray to deliver comprehensive solutions that enhance both the quality and efficiency of healthcare systems worldwide. Mindray's business model is intrinsically tied to innovation and global distribution. The company continually invests in research and development, a strategic move that keeps it at the forefront of medical technology advancement. Its R&D centers — strategically located in China, the U.S., and Europe — work tirelessly to push the boundaries of medical technology and address the evolving needs of healthcare professionals. In tandem with its technological prowess, Mindray crafts a robust network of distribution that ensures its advanced devices reach hospitals and clinics across over 190 countries. This expansive market presence, coupled with competitive pricing strategies, has propelled the company to secure a formidable foothold in both emerging and developed economies, thereby transforming the accessibility and delivery of healthcare services on a global scale.

Intrinsic Value
372.4 CNY
Undervaluation 31%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Accounts Receivables?
Accounts Receivables
4B CNY

Based on the financial report for Sep 30, 2024, Shenzhen Mindray Bio-Medical Electronics Co Ltd's Accounts Receivables amounts to 4B CNY.

What is Shenzhen Mindray Bio-Medical Electronics Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
17%

Over the last year, the Accounts Receivables growth was 9%. The average annual Accounts Receivables growth rates for Shenzhen Mindray Bio-Medical Electronics Co Ltd have been 27% over the past three years , 17% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.